Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy

Ujjawal H. Gandhi(Vanderbilt University Medical Center), Robert F. Cornell(Vanderbilt University Medical Center), Arjun Lakshman(Mayo Clinic in Arizona), Zhubin Gahvari(University of Wisconsin–Madison), Elizabeth McGehee(The University of Texas Southwestern Medical Center), Megan H. Jagosky(Carolinas Healthcare System), Ridhi Gupta(Cancer Prevention Institute of California), William Varnado(University of Alabama at Birmingham), Mark A. Fiala(Washington University in St. Louis), Saurabh Chhabra(Medical College of Wisconsin), Ehsan Malek(University Hospitals Seidman Cancer Center), Joshua Mansour(Medical University of South Carolina), Barry Paul(Duke University), Alyssa Barnstead(Oregon Health & Science University), Saranya Kodali(University of Vermont), Amarendra Kumar Neppalli(Medical University of South Carolina), Michaela Liedtke(Cancer Prevention Institute of California), Swapna Narayana(Medical College of Wisconsin), Kelly Godby(University of Alabama at Birmingham), Yubin Kang(Duke University), Ankit Kansagra(The University of Texas Southwestern Medical Center), Elvira Umyarova(University of Vermont), Emma C. Scott(Oregon Health & Science University), Parameswaran Hari(Medical College of Wisconsin), Ravi Vij(Washington University in St. Louis), Saad Z. Usmani(Carolinas Healthcare System), Natalie S. Callander(University of Wisconsin–Madison), Shaji Kumar(Mayo Clinic in Arizona), Luciano J. Costa(University of Alabama at Birmingham)
Leukemia
March 11, 2019
Cited by 614

Abstract


Related Papers

No related papers found

Powered by citation graph analysis